On March 16, faculty and staff of MD Anderson and Instituto Nacional de Enfermedades Neoplásicas (INEN), as well as representatives of the government of Peru, met in Lima to formally sign a sister institution (SI) agreement.
Administered by MD Anderson's Global Academic Programs (GAP), SI agreements are a concrete expression of MD Anderson's belief that an institution is a valuable partner in the fight against cancer, as well as a willingness to engage collaboratively to further the aims of helping patients and eradicating cancer. In INEN's case, the development of this partnership has been nearly four decades in the making.
When talking to major players in cancer care, especially leukemia, there is a name routinely referenced. For baseball fans it would be akin to speaking of Mantle, Ruth or DiMaggio, or to the physics crowd similar to discussing Planck, Feynman or Einstein.
It takes a few discussions with prominent researchers before one realizes there are certain individuals who have had a comparable impact on the world of oncology. An impact, which throughout the remaining story of man will silently ripple, often imperceptible to those who would learn or benefit from it.